Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + hydrochlorothiazide versus telmisartan monotherapy in severe hypertension
2008-007711-32Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Telmisartan 80 mg + hydrochlorothiazide 25 mg FDC with Telmisartan 80 mg monotherapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2009; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-007711-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007711-32.